Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 37 Records) |
| Query Trace: Fibrosis and HSD17B13[original query] |
|---|
| HSD17B13 rs72613567 protects against liver diseases and histological progression of nonalcoholic fatty liver disease: a systematic review and meta-analysis. European review for medical and pharmacological sciences 2020 9 24 (17): 8997-9007. Wang P, Wu C-X, Li Y, Shen |
| Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program. PloS one 2020 15 (8): e0237430. Serper Marina, Vujkovic Marijana, Kaplan David E, Carr Rotonya M, Lee Kyung Min, Shao Qing, Miller Donald R, Reaven Peter D, Phillips Lawrence S, O'Donnell Christopher J, Meigs James B, Wilson Peter W F, Vickers-Smith Rachel, Kranzler Henry R, Justice Amy C, Gaziano John M, Muralidhar Sumitra, Pyarajan Saiju, DuVall Scott L, Assimes Themistocles L, Lee Jennifer S, Tsao Philip S, Rader Daniel J, Damrauer Scott M, Lynch Julie A, Saleheen Danish, Voight Benjamin F, Chang Kyong-Mi, |
| Insights into genetic variants associated with NASH-fibrosis from metabolite profiling. Human molecular genetics 2020 Jul . Mann Jake P, Pietzner Maik, Wittemans Laura B, Rolfe Emmanuela De Lucia, Kerrison Nicola D, Imamura Fumiaki, Forouhi Nita G, Fauman Eric, Allison Michael E, Griffin Jules L, Koulman Albert, Wareham Nicholas J, Langenberg Claud |
| Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients. Gastroenterology research and practice 2020 5 2020 4216451. De Benedittis Carla, Bellan Mattia, Crevola Martina, Boin Elena, Barbaglia Matteo Nazzareno, Mallela Venkata Ramana, Ravanini Paolo, Ceriani Elisa, Fangazio Stefano, Sainaghi Pier Paolo, Burlone Michela Emma, Minisini Rosalba, Pirisi Mar |
| Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 2020 Apr . Seko Yuya, Yamaguchi Kanji, Tochiki Nozomi, Yano Kota, Takahashi Aya, Okishio Shinya, Kataoka Seita, Okuda Keiichiroh, Umemura Atsushi, Moriguchi Michihisa, Tanaka Saiyu, Mori Kojiroh, Okanoue Takeshi, Itoh Yoshi |
| The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. Alimentary pharmacology & therapeutics 2020 4 51 (11): 1160-1168. Mederacke Young-Seon, Kirstein Martha M, Großhennig Anika, Marhenke Silke, Metzler Frauke, Manns Michael P, Vogel Arndt, Mederacke Ingm |
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort.
Journal of hepatology 2020 Apr . Anstee Quentin M, Darlay Rebecca, Cockell Simon, Meroni Marica, Govaere Olivier, Tiniakos Dina, Burt Alastair D, Bedossa Pierre, Palmer Jeremy, Liu Yang-Lin, Aithal Guruprasad P, Allison Michael, Yki-Järvinen Hannele, Vacca Michele, Dufour Jean-Francois, Invernizzi Pietro, Prati Daniele, Ekstedt Mattias, Kechagias Stergios, Francque Sven, Petta Salvatore, Bugianesi Elisabetta, Clement Karine, Ratziu Vlad, Schattenberg Jörn M, Valenti Luca, Day Christopher P, Cordell Heather J, Daly Ann K, |
| HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson's Disease. JHEP reports : innovation in hepatology 2020 2 1 (1): 2-8. Ferenci Peter, Pfeiffenberger Jan, Stättermayer Albert Friedrich, Stauber Rudolf E, Willheim Claudia, Weiss Karl H, Munda-Steindl Petra, Trauner Michael, Schilsky Michael, Zoller Hei |
| Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Dec . Israelsen Mads, Juel Helene Bæk, Detlefsen Sönke, Madsen Bjørn Stæhr, Rasmussen Ditlev Nytoft, Larsen Trine R, Kjærgaard Maria, Fernandes Jensen Mary Jo, Stender Stefan, Hansen Torben, Krag Aleksander, Thiele Maja, |
| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. Journal of hepatology 2020 11 74 (4): 775-782. Bianco Cristiana, Jamialahmadi Oveis, Pelusi Serena, Baselli Guido, Dongiovanni Paola, Zanoni Irene, Santoro Luigi, Maier Silvia, Liguori Antonio, Meroni Marica, Borroni Vittorio, D'Ambrosio Roberta, Spagnuolo Rocco, Alisi Anna, Federico Alessandro, Bugianesi Elisabetta, Petta Salvatore, Miele Luca, Vespasiani-Gentilucci Umberto, Anstee Quentin M, Stickel Felix, Hampe Jochen, Fischer Janett, Berg Thomas, Fracanzani Anna Ludovica, Soardo Giorgio, Reeves Helen, Prati Daniele, Romeo Stefano, Valenti Lu |
| The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD. Clinical and translational gastroenterology 2021 Sep 12 (9): e00400. Vilar-Gomez Eduardo, Pirola Carlos J, Sookoian Silvia, Wilson Laura A, Liang Tiebing, Chalasani Na |
| Epidemiology and risk-stratification of NAFLD-associated HCC. Journal of hepatology 2021 8 75 (6): 1476-1484. Ioannou George |
| Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease. Hepatology international 2021 Jun . Paternostro Rafael, Staufer Katharina, Traussnigg Stefan, Stättermayer Albert-Friedrich, Halilbasic Emina, Keritam Omar, Meyer Elias L, Stift Judith, Wrba Fritz, Sipos Bence, Canbay Ali, Schlattjan Martin, Aigner Elmar, Datz Christian, Stickel Felix, Schafmayer Clemens, Hampe Jochen, Buch Stephan, Prager Gerhard, Munda Petra, Mandorfer Mattias, Ferenci Peter, Trauner Micha |
| Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease. Journal of clinical and translational hepatology 2021 Apr 9 (2): 194-202. Liu Wen-Yue, Eslam Mohammed, Zheng Kenneth I, Ma Hong-Lei, Rios Rafael S, Lv Min-Zhi, Li Gang, Tang Liang-Jie, Zhu Pei-Wu, Wang Xiao-Dong, Byrne Christopher D, Targher Giovanni, George Jacob, Zheng Ming-H |
| The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. Alimentary pharmacology & therapeutics 2021 May . Ajmera Veeral, Liu Amy, Bettencourt Ricki, Dhar Debanjan, Richards Lisa, Loomba Roh |
| Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.
The Lancet. Oncology 2021 12 23 (1): 161-171. Trépo Eric, Caruso Stefano, Yang Jie, Imbeaud Sandrine, Couchy Gabrielle, Bayard Quentin, Letouzé Eric, Ganne-Carrié Nathalie, Moreno Christophe, Oussalah Abderrahim, Féray Cyrille, Blanc Jean Frédéric, Clément Bruno, Hillon Patrick, Boursier Jérôme, Paradis Valérie, Calderaro Julien, Gnemmi Viviane, Nault Jean-Charles, Guéant Jean-Louis, Devière Jacques, Archambeaud Isabelle, Vitellius Carole, Turlin Bruno, Bronowicki Jean-Pierre, Gustot Thierry, Sutton Angela, , Ziol Marianne, Nahon Pierre, Zucman-Rossi Jessi |
| Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience 2022 9 25 (9): 104949. Sen Partho, Govaere Olivier, Sinioja Tim, McGlinchey Aidan, Geng Dawei, Ratziu Vlad, Bugianesi Elisabetta, Schattenberg Jörn M, Vidal-Puig Antonio, Allison Michael, Cockell Simon, Daly Ann K, Hyötyläinen Tuulia, Anstee Quentin M, Oreši? Mat |
| Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study. Hepatology international 2022 Jul . Yang Aruhan, Zhu Xiaoxue, Zhang Lei, Zhang Yingwen, Zhang Dezhi, Jin Meishan, Niu Junqi, Zhang Huimao, Ding Yanhua, Lv Guoy |
| MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery. International journal of molecular sciences 2022 12 23 (24): . Kalinowski Piotr, Smyk Wiktor, Nowosad Ma?gorzata, Paluszkiewicz Rafa?, Micha?owski ?ukasz, Ziarkiewicz-Wróblewska Bogna, Weber Susanne N, Milkiewicz Piotr, Lammert Frank, Zieniewicz Krzysztof, Krawczyk Marc |
| Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients. International journal of molecular sciences 2022 10 23 (19): . Gil-Gómez Antonio, Rojas Ángela, García-Lozano María R, Muñoz-Hernández Rocío, Gallego-Durán Rocío, Maya-Miles Douglas, Montero-Vallejo Rocío, Gato Sheila, Gallego Javier, Francés Rubén, Soriano Germán, Ampuero Javier, Romero-Gómez Manu |
| Genetic Variants Determine Treatment Response in Autoimmune Hepatitis. Journal of personalized medicine 2023 3 13 (3): . Zandanell Stephan, Balcar Lorenz, Semmler Georg, Schirmer Alex, Leitner Isabella, Rosenstatter Lea, Niederseer David, Sotlar Karl, Schneider Anna-Maria, Strasser Michael, Gensluckner Sophie, Feldman Alexandra, Datz Christian, Aigner Elm |
| Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 1 . Rutledge Stephanie M, Soper Emily R, Ma Ning, Pejaver Vikas, Friedman Scott L, Branch Andrea D, Kenny Eimear E, Belbin Gillian M, Abul-Husn Noura |
| Liver phenotypes in PCOS: Analysis of exogenous and inherited risk factors for liver injury in two European cohorts. Liver international : official journal of the International Association for the Study of the Liver 2023 1 . Smyk Wiktor, Papapostoli Ifigeneia, ?orniak Micha?, Sklavounos Panagiotis, Blukacz ?ukasz, Madej Pawe?, Koutsou Andreani, Weber Susanne N, Friesenhahn-Ochs Bettina, Cebula Maciej, Bosowska Joanna, Solomayer Erich-Franz, Hartleb Marek, Milkiewicz Piotr, Lammert Frank, Stokes Caroline S, Krawczyk Marc |
| The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 2024 6 . Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Rohit Loomba, Veeral Ajme |
| Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and research in hepatology and gastroenterology 2024 6 48 (7): 102389. Elias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, Mira Thing, Puria Nabilou, Nina Kimer, Anders Ellekaer Junker, Anne-Sofie Houlberg Jensen, Børge Grønne Nordestgaard, Stefan Stender, Lise Lotte Glu |
| Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. Nutrients 2024 6 16 (12): . Nantawat Satthawiwat, Thananya Jinato, Sawannee Sutheeworapong, Natthaporn Tanpowpong, Natthaya Chuaypen, Pisit Tangkijvani |
| Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. American journal of biological anthropology 2024 5 e24979. Maria C Rieman-Klingler, Jinho Jung, Kaleb Tesfai, Rohit Loomba, Amy L N |
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. Genes 2024 4 15 (4): . Nehal Elmansoury, Ahmed A Megahed, Ahmed Kamal, Nefertiti El-Nikhely, Marina Labane, Manal Abdelmageed, Ann K Daly, Ahmed Wah |
| Differential effects of genetic polymorphism on comorbid disease in metabolic dysfunction-associated steatotic liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 4 . Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Takeshi Okanoue, Yoshito It |
| Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease. Diabetes research and clinical practice 2024 12 219 111960. Zobair M Younossi, J Michael Estep, Sean Felix, Brian Lam, Zaid Younossi, Andrei Racila, Maria Stepano |
- Page last reviewed:Feb 1, 2024
- Content source: